Praxis Precision Medicines (PRAX) Operating Expenses (2019 - 2026)

Praxis Precision Medicines' Operating Expenses history runs 8 years deep, the most recent figure standing at $105.9 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 41.66% year-over-year to $105.9 million in Q1 2026; TTM through Mar 2026 was $357.3 million, a 48.19% increase from a year earlier, with the FY2025 full-year figure at $326.2 million, up 56.29% from the prior year.
• Operating Expenses advanced to $105.9 million in Q1 2026 per PRAX's latest filing, from $97.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $105.9 million in Q1 2026 and bottomed at $26.0 million in Q3 2023.
• The 5-year median for Operating Expenses is $57.1 million (2024), against an average of $57.9 million.
• Across the five-year window, Operating Expenses slumped 43.68% in 2023 and jumped 152.18% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $41.5 million in 2022, then tumbled by 31.68% to $28.3 million in 2023, then soared by 152.18% to $71.4 million in 2024, then surged by 35.88% to $97.0 million in 2025, then grew by 9.08% to $105.9 million in 2026.
• Per Business Quant, the three latest PRAX Operating Expenses figures stand at $105.9 million (Q1 2026), $97.0 million (Q4 2025), and $78.4 million (Q3 2025).